Odyssey HealthCare Inc. will pay $13 million to end federal investigations that grew out of two whistleblower actions brought under the False Claims Act, after striking deals with the U.S. Department of Justice, the U.S. Department of Health and Human Services and the Office of the Inspector General.
The $100 million stumbling block that has been preventing money manager Mario Gabelli from settling antitrust charges brought by the Department of Justice has been removed, clearing the way for a deal to be finalized.
The Boeing Company will pay $615 million to settle U.S. Department of Justice probes into allegations that Boeing illegally obtained and used competitors' information to win contracts worth billions of dollars from NASA and the Air Force.
Two more lawyers are leaving Milberg Weiss Bershad & Schulman, the law firm indicted last month for allegedly paying kickbacks to lead plaintiffs in nearly 150 class action suits.
Investor Mario Gabelli agreed Tuesday to settle a civil fraud suit with the U.S. Department of Justice, which alleged that he used sham business operations to cheat the government out of millions of dollars through auctions of cell phone licenses.
Less than a month after Mario Gabelli agreed to pay $100 million to settle allegations of share manipulation, the famed money manager is in talks with the U.S. Department of Justice in order to resolve civil fraud claims in a separate case alleging the tycoon’s use of sham businesses in federal cell phone spectrum auctions.
Most companies rarely let the public see behind their closed doors, especially in the midst of a scandal. But thanks to a speech by Boeing’s general counsel that was leaked to the public, the aerospace giant’s current legal troubles and their possible repercussions have been put on view for the world to see.
Two seasoned Orrick, Herrington & Sutcliffe LLP biotech litigators have defected to join Sidley Austin Brown & Wood LLP as partners in the firm’s intellectual property group in New York.
A federal court has once again dismissed a lawsuit filed by the Promega Corp. against Roche and Applied Biosystems, which alleged that the companies committed fraud against the U.S. government, Roche said.
A federal judge has dismissed biotech company Promega Corp.'s lawsuit in a long-running legal battle against rival Hoffmann LaRoche and its partner, Applera Corp, but Promega two weeks to provide additional details in an amended lawsuit.